The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.

China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

All products are independently selected by our editors. If you buy something, we may earn an affiliate commission.

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...